Spatially confined photoacoustic effects of responsive nanoassembly boosts lysosomal membrane permeabilization and immunotherapy of triple-negative breast cancer

被引:0
|
作者
Li, Kunlin [1 ]
Li, Lin [1 ]
Xie, Xiyue [1 ]
Zhu, Jing [1 ]
Xia, Daqing [1 ]
Xiang, Lunli [1 ]
Cai, Kaiyong [1 ]
Zhang, Jixi [1 ]
机构
[1] Chongqing Univ, Coll Bioengn, Minist Educ, Key Lab Biorheol Sci & Technol, 174 Shazheng St, Chongqing 400044, Peoples R China
基金
中国国家自然科学基金;
关键词
Tumor immunotherapy; Responsive self-assembly; Photoacoustic effects; Lysosomal membrane permeabilization; Endoplasmic reticulum stress; THERAPY;
D O I
10.1016/j.actbio.2024.08.021
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Although immunogenic cell death (ICD) induced by lysosomal membrane permeabilization (LMP) evidently enhance the effectiveness of antitumor immunity for triple-negative breast cancer (TNBC) with poor immunogenicity, their potential is increasingly restricted by the development of other death pathways and the repair of lysosomes by endoplasmic reticulum (ER) during LMP induction. Herein, a poly- dopamine nanocomposite with i-motif DNA modified and BNN6 loaded is prepared toward boosting LMP and immunotherapy of TNBC by synergy of spatially confined photoacoustic (PA) effects and nitric oxide. Combining the high-frequency pulsed laser (40 0 0 kHz) with the intra-lysosomal assembly of nanocomposites produced spatially confined and significantly boosted PA effects (4.8-fold higher than the individually dispersed particles extracellular), suppressing damage to other cellular components and selectively reducing lysosomal integrity to 19.2 %. Simultaneously, the releasing of nitric oxide inhibited the repair of lysosomes by ER stress, causing exacerbated LMP. Consequently, efficient immune activation was achieved, including the abundant releasing of CRT/HMGB1 (5.93-6.8-fold), the increasing maturation of dendritic cells (3.41-fold), and the fostered recruitment of CD4+/CD8+ T cells (3.99-3.78-fold) in vivo . The study paves a new avenue for the rational design and synergy of confined energy conversion and responsive nanostructures to achieve the treatment of low immunogenicity tumors.
引用
收藏
页码:381 / 395
页数:15
相关论文
共 50 条
  • [31] Spatial predictors of immunotherapy response in triple-negative breast cancer
    Xiao Qian Wang
    Esther Danenberg
    Chiun-Sheng Huang
    Daniel Egle
    Maurizio Callari
    Begoña Bermejo
    Matteo Dugo
    Claudio Zamagni
    Marc Thill
    Anton Anton
    Stefania Zambelli
    Stefania Russo
    Eva Maria Ciruelos
    Richard Greil
    Balázs Győrffy
    Vladimir Semiglazov
    Marco Colleoni
    Catherine M. Kelly
    Gabriella Mariani
    Lucia Del Mastro
    Olivia Biasi
    Robert S. Seitz
    Pinuccia Valagussa
    Giuseppe Viale
    Luca Gianni
    Giampaolo Bianchini
    H. Raza Ali
    Nature, 2023, 621 : 868 - 876
  • [32] Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancer
    Denkert, Carsten
    Schneeweiss, Andreas
    Rey, Julia
    Karn, Thomas
    Hattesohl, Akira
    Weber, Karsten E.
    Rachakonda, Sivaramakrishna
    Braun, Michael
    Huober, Jens
    Jank, Paul
    Sinn, Hans-Peter
    Zahm, Dirk-Michael
    Felder, Barbel
    Hanusch, Claus
    Teply-Szymanski, Julia
    Marme, Frederik
    Fehm, Tanja
    Thomalla, Jorg
    V. Sinn, Bruno
    Stiewe, Thorsten
    Marczyk, Michal
    Blohmer, Jens-Uwe
    van Mackelenbergh, Marion
    Schem, Christian
    Staib, Peter
    Link, Theresa
    Muller, Volkmar
    Stickeler, Elmar
    Stover, Daniel G.
    Solbach, Christine
    Metzger-Filho, Otto
    Jackisch, Christian
    Geyer Jr, Charles E.
    Fasching, Peter A.
    Pusztai, Lajos
    Nekljudova, Valentina
    Untch, Michael
    Loibl, Sibylle
    CELL REPORTS MEDICINE, 2024, 5 (11)
  • [33] Novel immunotherapy approach for metastatic triple-negative breast cancer
    Griffin, Paul
    Jain, Riya
    Le, Sean
    Rajapakse, Kyle
    Miller, Wilson
    Andarawewa, Kumari
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (10)
  • [34] Combining Chemotherapy and Immunotherapy for the Treatment of Triple-Negative Breast Cancer
    McArthur, Heather
    ONCOLOGY-NEW YORK, 2019, 33 (04): : 137 - 140
  • [35] Nanoparticle-Mediated Immunotherapy in Triple-Negative Breast Cancer
    Wang, Ruoyi
    Huang, Xu
    Chen, Xiaoxi
    Zhang, Yingchao
    ACS BIOMATERIALS SCIENCE & ENGINEERING, 2024, 10 (06): : 3568 - 3598
  • [36] Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer
    Mediratta, Karan
    El-Sahli, Sara
    D'Costa, Vanessa
    Wang, Lisheng
    CANCERS, 2020, 12 (12) : 1 - 36
  • [37] Efficacy of immunotherapy is attenuated with age in triple-negative breast cancer
    McAllister, Sandra S.
    Sceneay, Jaclyn
    Laszewski, Tyler
    DeCristo, Molly
    Ubellacker, Jessalyn
    Wilson, Kristin
    Qin, Yuanbo
    Hutchinson, John
    CANCER RESEARCH, 2018, 78 (13)
  • [38] Molecular mechanisms of immunotherapy resistance in triple-negative breast cancer
    Zheng, Yiwen
    Li, Shujin
    Tang, Hongchao
    Meng, Xuli
    Zheng, Qinghui
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [39] Tri-component programmable nanoregulator with Three-pronged penetration boosts immunotherapy of Triple-Negative breast cancer
    Li, Ziying
    Shi, Huifang
    Xie, Huanzhang
    Yang, Ya
    Zheng, Yilin
    Chen, Haijun
    Gao, Yu
    CHEMICAL ENGINEERING JOURNAL, 2022, 439
  • [40] 'IMpassionate conflicts' in immunotherapy trials for metastatic triple-negative breast cancer
    Voorwerk, L.
    Kok, M.
    ANNALS OF ONCOLOGY, 2021, 32 (08) : 947 - 949